Sumatriptan Succinate And Naproxen Sodium Tablet
Pricing Report NDC 44183-850-09

Latest NADAC: $17.87426 per EA · Effective Aug 23, 2023 · Est. package price $160.87 (9 EA)

Current Package Pricing Information

The latest wholesale acquisition cost for Sumatriptan Succinate And Naproxen Sodium (NDC 44183-850-09) is $17.87426 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 23, 2023.

As a a human prescription drug provided by Currax Pharmaceuticals Llc Dba Cypress, Hawthorn, Macoven, this medication is distributed in a 9 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$17.87426
Per EA

Effective Date
Aug 23, 2023
Billable Units
9 EA
Estimated Package Price
$160.87
Data Status
As of Sep 27, 2023
C/I - Chain or Independent Pharmacy
Package NDC
Description
9 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2018, the NADAC wholesale price for (NDC ) has moved within a range of $14.75495 to $64.21897 per EA. Over this 5 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$14.7550 - $64.2190
Market Volatility
335.24% Variance
Latest Trend
3.17%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 23, 2023 $17.87426 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 23, 2023 $17.87426 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Jul 19, 2023 $17.32524 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 21, 2023 $19.11596 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 22, 2023 $18.84633 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 22, 2023 $18.84633 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic
Feb 22, 2023 $18.99691 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 18, 2023 $14.75495 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 21, 2022 $26.51161 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 23, 2022 $31.83148 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 21, 2022 $27.00395 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 21, 2022 $27.00395 EAC/I - Chain or Independent PharmacyCode 4, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026